Telerehabilitation in Carpal Tunnel Syndrome
Effectiveness of a Multimodal Telerehabilitation Program Combining Pain Neuroscience Education and Therapeutic Exercise for Patients With Carpal Tunnel Syndrome: A Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
Carpal tunnel syndrome (CTS) is a compressive peripheral neuropathy characterized by pain, tingling sensation and paresthesia in the territory of the median nerve. These symptoms cause significant functional impairment that affects patients' quality of life. Pain neuroscience education (PNE) combined with therapeutic exercise (TE) has shown good results in patients with chronic pain, but the effects of this multimodal treatment via telerehabilitation have not been studied in patients with CTS. Telerehabilitation has demonstrated clinical and functional outcomes as effective as face-to-face interventions, being a good alternative to improve accessibility to rehabilitation care in a context of pandemic and social distancing. The purpose of this study is to provide coordinated, patient-centered care by implementing a Telerehabilitation model for patients with severe CTS. The objective of this study was to compare the effectiveness of a multimodal therapy program (TE plus PNE) versus a unimodal treatment (TE) in patients with CTS. A Randomized Controlled Trial, simple-blind and multicenter study will be conducted. Patients will be randomly assigned to the multimodal treatment group (TE plus PNE) or to the unimodal treatment group (TE). At admission, an investigator blinded to treatment assignment will conduct data collection. The measurements will be the following outcomes: a) Pain Catastrophizing Scale; b) Tampa Scale for Kinesiophobia-11; c) Numerical Rating Scale (NRS); d) Boston Carpal Tunnel Questionnaire; e) Hospital Anxiety and Depression Scale; f) Quality of Life, using the EQ-5D instrument; g) Patient's global impression of change; h) Katz Diagram; These evaluations will be performed again at week 6 and 12.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
January 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 6, 2022
CompletedAugust 3, 2022
August 1, 2022
6 months
November 27, 2021
August 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from Baseline Pain Catastrophizing Scale (PCS) at 6 and 12 weeks
To assess catastrophic thinking as a response to pain through 13 statements with 4 possible options from 1 "not at all" to 4 "all the time". a higher score indicates a higher catastrophic thinking
Baseline (0 weeks), 6 weeks and 12 week
Change from Baseline Tampa Scale for Kinesiophobia-11 (TSK-11) at 6 and 12 weeks
Kinesiophobia will be evaluated by Tampa Scale for Kinesiophobia (TSK-11SV) (Spanish adaptation. Gómez-Pérez, López-Martínez y Ruiz-Párraga, 2011). Scoring: Items are summed, with a total score from 11-44 and higher values represent a worse outcome (more pain interference in behavior).
Baseline (0 weeks), 6 weeks and 12 week
Change from Baseline Numerical rating scale (NRS) at 6 and 12 weeks
The patient must rate his or her pain on a defined scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable.
Baseline (0 weeks), 6 weeks and 12 week
Secondary Outcomes (7)
Change from Baseline Boston Carpal Tunnel Questionnaire (BCTQ) at 6 and 12 weeks
Baseline (0 weeks), 6 weeks and 12 week
Change from Baseline Hospital Anxiety and Depression Scale (HAD) at 6 and 12 weeks
Baseline (0 weeks), 6 weeks and 12 week
Change from Baseline EQ-5D at 6 and 12 weeks
Baseline (0 weeks), 6 weeks and 12 week
Hand diagrams
Baseline (0 weeks)
Change from Baseline Muscular endurance at 6 and 12 weeks
Baseline (0 weeks), 6 weeks and 12 week
- +2 more secondary outcomes
Study Arms (2)
Multimodal treatment
EXPERIMENTALTherapeutic Exercise plus Pain Neuroscience Education
Unimodal treatment
ACTIVE COMPARATORTherapeutic Exercise
Interventions
A multimodal telerehabilitation intervention will be conducted through Whatsapp video calls. The combined treatment includes: 1) One 30-minute session of education in neurosciences of pain, using audiovisual material with examples and metaphors to improve the patient's understanding. In addition, two sessions of reinforcement of key contents will be held every 15 days; 2) Therapeutic exercise program: active wrist and finger exercises, stretching, mobilization exercises of the median nerve, and aerobic exercise (brisk walking). Each exercise will be dosed on a personalized basis, with a perceived exertion of 4-5 on the Borg scale. Therapeutic exercise will be self-administered, 3 sessions per week for 6 weeks. Telerehabilitation sessions will be performed every 15 days to monitor adherence and adjust the exercise dose.
An unimodal telerehabilitation intervention will be performed through Whatsapp video calls. The treatment will include only a therapeutic exercise program: active wrist and finger exercises, stretching, mobilization exercises of the median nerve, and aerobic exercise (brisk walking). Each exercise will be dosed on a personalized basis, with a perceived exertion of 4-5 on the Borg scale. Therapeutic exercise will be self-administered, 3 sessions per week for 6 weeks. Telerehabilitation sessions will be performed every 15 days to monitor adherence and adjust the exercise dose.
Eligibility Criteria
You may qualify if:
- Over 20 years of age, severe CTS medical diagnosis, duration of symptoms for more than three months, access to a smartphone with internet, and acceptance to participate in the study.
You may not qualify if:
- Inability to understand instructions, non-controlled mental health pathology, cognitive problems and previous surgery in the upper limb.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Clínico La Floridalead
- University of Chilecollaborator
- University of Valenciacollaborator
- Hospital San Josécollaborator
- Hospital Provincia Cordilleracollaborator
Study Sites (1)
Hospital la Florida
Santiago, Chile
Related Publications (1)
Nunez-Cortes R, Cruz-Montecinos C, Torreblanca-Vargas S, Tapia C, Gutierrez-Jimenez M, Torres-Gangas P, Calatayud J, Perez-Alenda S. Effectiveness of adding pain neuroscience education to telerehabilitation in patients with carpal tunnel syndrome: A randomized controlled trial. Musculoskelet Sci Pract. 2023 Oct;67:102835. doi: 10.1016/j.msksp.2023.102835. Epub 2023 Jul 28.
PMID: 37572618DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The investigator at each center responsible for conducting the study evaluations will be blinded to group assignment. A second investigator will be responsible for generating randomization, sequencing, enrolling participants, and assigning participants to treatment. Patients will be blinded to the assigned group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 27, 2021
First Posted
January 11, 2022
Study Start
January 15, 2022
Primary Completion
July 6, 2022
Study Completion
July 6, 2022
Last Updated
August 3, 2022
Record last verified: 2022-08